Applications Now Open - Advancing Treatment Of Repeated Mild Traumatic Brain Injury
CHARLESTON, S.C., Sept. 16, 2020 /PRNewswire/ -- In partnership with BrightFocus Foundation, the Medical Technology Enterprise Consortium (MTEC) today announced a request for proposals for research that will enable the advancement of candidate drugs for the treatment of repeated mild traumatic brain injury (mTBI).
- CHARLESTON, S.C., Sept. 16, 2020 /PRNewswire/ -- In partnership with BrightFocus Foundation, the Medical Technology Enterprise Consortium (MTEC) today announced a request for proposals for research that will enable the advancement of candidate drugs for the treatment of repeated mild traumatic brain injury (mTBI).
- BrightFocus Foundation and MTEC have come together to address a critical need in TBI research.
- Repeated mTBIs which are common in contact sports and military settings have been indicated as a risk factor in developing various neurodegenerative diseases.
- MTEC and BrightFocus are jointly funding up to $500,000, with the goal of catapulting drugs for the treatment of repeated mTBI toward human clinical trials.